Published online May 15, 2024. doi: 10.4251/wjgo.v16.i5.1705
Revised: February 28, 2024
Accepted: April 1, 2024
Published online: May 15, 2024
Processing time: 128 Days and 9.8 Hours
Colorectal cancer (CRC) remains one of the most commonly diagnosed and deadliest types of cancer worldwide. CRC displays a desmoplastic reaction (DR) that has been inversely associated with poor prognosis; less DR is associated with a better prognosis. This reaction generates excessive connective tissue, in which cancer-associated fibroblasts (CAFs) are critical cells that form a part of the tumor microenvironment. CAFs are directly involved in tumorigenesis through different mechanisms. However, their role in immunosuppression in CRC is not well understood, and the precise role of signal transducers and activators of transcription (STATs) in mediating CAF activity in CRC remains unclear. Among the myriad chemical and biological factors that affect CAFs, different cytokines mediate their function by activating STAT signaling pathways. Thus, the harmful effects of CAFs in favoring tumor growth and invasion may be modulated using STAT inhibitors. Here, we analyze the impact of different STATs on CAF activity and their immunoregulatory role.
Core Tip: The desmoplastic reaction (DR) is characterized by the excessive accumulation of connective tissue that encapsulates the tumor, made up of the recruitment of immune cells, activated fibroblasts, capillary formation, as well as the secretion of extracellular matrix proteins such as collagens, fibronectin, tenascin C, periostin, laminin, growth factors, cytokines, and chemokines. DR has been associated with the poor prognosis of patients and has been reported in various solid tumors: Ductal adenocarcinoma of the pancreas, breast cancer, lung cancer, ovarian cancer, head and neck cancer, colon cancer, and colorectal cancer (CRC), among others. The cells responsible for the generation of DR are cancer-associated fibroblasts, and together, they promote tumor development by increasing the proliferation, invasion, and migration of tumor cells, as well as resistance to chemotherapy and radiotherapy. In fact, the expression of stromal genes associated with DR has been reported to define a poor prognosis in CRC patients.